insights_auto
Why is PTGX up 2,73%?
Dive Deeperchevron_right
PTGX:NASDAQ
Protagonist Therapeutics Inc
143,73 US$
arrow_upward
+2,73%(+3,82) 1D
143,00 US$
arrow_downward
-0,51% (-0,73)bedtimeAfter hours
Closed: 9 ოქტ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PTGX...
Open
139,91 US$
High
146,30 US$
Low
138,95 US$
Mkt. cap
9,30 მლრდ.
Avg. vol.
714,90 ათ.
Volume
763,10 ათ.
P/E ratio
138,59
52-wk high
160,81 US$
52-wk low
65,77 US$
EPS
1,04 US$
Beta
1,53
Shares outstanding
64,71 მლნ.
No. of employees
141
Open
139,91 US$
High
146,30 US$
Low
138,95 US$
Mkt. cap
9,30 მლრდ.
Avg. vol.
714,90 ათ.
Volume
763,10 ათ.
P/E ratio
138,59
52-wk high
160,81 US$
52-wk low
65,77 US$
EPS
1,04 US$
Beta
1,53
Shares outstanding
64,71 მლნ.
No. of employees
141
News stories
From web sources and news partners
https://www.dars.gov.et/
·
2 დღის წინ
PTGX Q2 2026 Earnings: EPS Beats Consensus by 7.83% as Shares Edge Higher - Revenue Breakdown Analysis
https://www.dars.gov.et/
·
2 თვის წინ
PTGX Q1 2026 Earnings: Unexpected Profit Delivers 109.2% EPS Surprise as Shares Slip - Earnings Momentum Score
About Protagonist Therapeutics Inc
CEO-
Employees141
Founded2006
HeadquartersNewark, კალიფორნია, ამერიკის შეერთებული შტატები
Sector-
Websiteprotagonist-inc.com